STOCK TITAN

UL Solutions Inc. Form 4 Filings

ULS NYSE

Every Form 4 that UL Solutions Inc. (ULS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow ULS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ULS filings page.

Rhea-AI Summary

UL Solutions Inc. (symbol: ULS) is the issuer of record for a Form 4 filing submitted to the SEC. WILLIAMS GEORGE A reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. (ULS) reported that director George A. Williams received three accruals of dividend-equivalent Deferred Restricted Stock Units (DRSUs) on September 10, 2026, covering an aggregate of 19 DRSUs, each representing one share of Class A Common Stock. These DRSUs relate to prior director awards and vest on the same schedules as the underlying DRSUs: one tranche tied to DRSUs that vested on May 1, 2025, one tied to DRSUs that vested on May 20, 2026, and one tied to DRSUs scheduled to vest on the earlier of May 20, 2027 or the annual meeting following the May 20, 2026 grant date, all to be settled in shares under the company’s Non-Employee Director Deferred Compensation Plan.

Rhea-AI Summary

UL Solutions Inc. (symbol: ULS) is the issuer of record for a Form 4 filing submitted to the SEC. Uggetti Alberto reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. (ULS) reported that executive vice president and chief commercial officer Alberto Uggetti received four small grants of Restricted Stock Units (RSUs) on September 10, 2026, representing dividend equivalent rights on existing RSUs. The grants cover 2, 4, 3 and 4 RSUs, each convertible into the same number of Class A common shares at no cash cost and vesting on the same three-installment schedules as the underlying RSU awards, with vesting dates tied to May 1, 2024, January 1, 2025, April 1, 2025 and April 1, 2026. No Rule 10b5-1 trading plan is reported for these awards.

Rhea-AI Summary

UL Solutions Inc. (symbol: ULS) is the issuer of record for a Form 4 filing submitted to the SEC. Torstad Elisabeth reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. (ULS) reported that director Elisabeth Torstad received grants of deferred restricted stock units (DRSUs) on September 10, 2026. These awards reflect 19 DRSUs in total, representing dividend equivalent rights tied to previously granted DRSUs, each convertible into one share of Class A Common Stock at no cash cost.

Rhea-AI Summary

UL Solutions Inc. (symbol: ULS) is the issuer of record for a Form 4 filing submitted to the SEC. THAMAN MICHAEL H reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. (ULS) director Michael H. Thaman reported an award of 4 Deferred Restricted Stock Units (DRSUs) on September 10, 2026, credited as dividend equivalent rights on DRSUs he already holds. Each DRSU represents a contingent right to receive one share of Class A Common Stock. After this accrual, he holds 2,213 DRSUs (including all accrued dividend equivalents), which vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026 grant date, and will be settled in shares under the company’s Non-Employee Director Deferred Compensation Plan. No Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

UL Solutions Inc. (symbol: ULS) is the issuer of record for a Form 4 filing submitted to the SEC. SUSMAN SALLY reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. (ULS) reported that director Sally Susman received small equity-based awards on September 10, 2026, in the form of 10 Deferred Restricted Stock Units (DRSUs), an additional 5 DRSUs, and 4 Restricted Stock Units (RSUs), each representing one share of Class A Common Stock. The awards reflect accrued dividend equivalent rights on DRSUs and RSUs already held. Following the RSU-related accrual, Susman directly holds 2,213 RSUs, including associated dividend equivalents, which vest by the earlier of May 20, 2027 or the next annual meeting after May 20, 2026. No Rule 10b5-1 trading plan is reported for these transactions.

Rhea-AI Summary

UL Solutions Inc. (symbol: ULS) is the issuer of record for a Form 4 filing submitted to the SEC. Shannon James M reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. (ULS) reported that director Shannon James M received three awards of Deferred Restricted Stock Units (DRSUs) on September 10, 2026, totaling 19 DRSUs. These awards represent accruals of dividend equivalent rights on previously granted DRSUs and each DRSU is a contingent right to one share of Class A Common Stock. The related DRSUs vested or will vest on May 1, 2025, May 20, 2026, and the earlier of May 20, 2027 or the next annual meeting, and will be settled in Class A shares according to the company’s Non-Employee Director Deferred Compensation Plan.

Rhea-AI Summary

UL Solutions Inc. (symbol: ULS) is the issuer of record for a Form 4 filing submitted to the SEC. Schjotz Gitte reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. (ULS) reported that Executive Vice President and Chief Business Operations and Innovation Officer Gitte Schjotz received several restricted stock unit (RSU) awards on September 10, 2026. These RSUs are dividend equivalent rights accruing on previously granted RSUs, cost $0.00 per unit, and each RSU represents one share of Class A Common Stock. The dividend equivalent RSUs vest in three equal installments on the first, second and third anniversaries of the related original grant dates of May 1, 2024, January 1, 2025, April 1, 2025 and April 1, 2026, respectively.

Rhea-AI Summary

UL Solutions Inc. (symbol: ULS) is the issuer of record for a Form 4 filing submitted to the SEC. Scanlon Jennifer F. reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. (ULS) reported that President and CEO Jennifer F. Scanlon received three restricted stock unit (RSU) awards on September 10, 2026 as compensation, not open-market purchases. The awards cover 43, 58 and 74 RSUs, each representing a contingent right to one share of Class A Common Stock.

The RSUs reflect dividend equivalent rights that accrued on RSUs she already holds and will vest proportionately with the underlying RSUs. The related RSUs vest in three equal installments on the first, second and third anniversaries of May 1, 2024, April 1, 2025 and April 1, 2026, respectively. No Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

UL Solutions Inc. (symbol: ULS) is the issuer of record for a Form 4 filing submitted to the SEC. Robinson Ryan D reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. (ULS) reported that Executive VP & CFO Ryan D. Robinson received three small awards of restricted stock units on September 10, 2026, covering 9, 12 and 18 RSUs, each representing a contingent right to one share of Class A Common Stock.

The RSUs represent accrued dividend equivalent rights on existing RSUs, and in each case vest proportionately and on the same three-installment schedule as the underlying RSUs, tied to grants dated May 1, 2024, April 1, 2025 and April 1, 2026. No Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

UL Solutions Inc. (ULS) reported that Senior VP & CAO Karen K. Pepping acquired additional restricted stock units (RSUs) on September 10, 2026 through three separate grant or award transactions. Each RSU represents a contingent right to receive one share of Class A Common Stock and reflects dividend equivalent rights accruing on RSUs she already holds, which will vest proportionately on the same multi-year schedules as the underlying RSUs granted in 2024, 2025, and 2026. No Rule 10b5-1 trading plan is reported for these awards.

Rhea-AI Summary

UL Solutions Inc. (symbol: ULS) is the issuer of record for a Form 4 filing submitted to the SEC. Kini Vikram reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. (ULS) director Vikram Kini reported an award of 4 Restricted Stock Units (RSUs) on September 10, 2026, representing accrued dividend equivalent rights on RSUs already held. Each RSU is a contingent right to receive one share of Class A Common Stock, and these dividend equivalents vest proportionately with the related RSUs.

The RSUs to which these dividend equivalents relate vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026 grant date. After this award, Kini holds 2,213 RSUs, including all accrued dividend equivalent rights, as direct ownership. No Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

UL Solutions Inc. (ULS) director Kevin Kennedy reported three acquisitions of equity-based awards on September 10, 2026. He received 10 Deferred Restricted Stock Units (DRSUs) and 5 additional DRSUs as dividend equivalent accruals on previously vested DRSUs, and 4 Restricted Stock Units (RSUs) as dividend equivalent accruals. Each RSU and DRSU represents a contingent right to receive one share of Class A Common Stock, and the RSU-related position totals 2,213 units after this transaction. No Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

UL Solutions Inc. (symbol: ULS) is the issuer of record for a Form 4 filing submitted to the SEC. Hooper Charles W reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. (ULS) reported that director Charles W. Hooper received three grants of Deferred Restricted Stock Units (DRSUs) on September 10, 2026, as accruals of dividend equivalent rights on DRSUs he already holds. The grants cover 10, 5, and 4 DRSUs, each representing one share of Class A Common Stock. These DRSUs vest and will be settled in Class A shares on the same schedules as their related underlying DRSUs, with vesting dates tied to prior awards in 2025 and 2026 and a future vesting date no later than the annual meeting following May 20, 2026, under the company’s Non-Employee Director Deferred Compensation Plan. No sales or disposals were reported and no Rule 10b5-1 trading plan is indicated.

Rhea-AI Summary

UL Solutions Inc. (symbol: ULS) is the issuer of record for a Form 4 filing submitted to the SEC. Hecker Friedrich reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. (ULS) director Friedrich Hecker received a grant of 4 Restricted Stock Units (RSUs) on September 10, 2026, representing dividend equivalent rights on existing RSUs and each convertible into one share of Class A Common Stock. These dividend equivalent RSUs vest proportionately with the underlying RSUs, on the earlier of May 20, 2027 or the date of the annual meeting following the May 20, 2026 grant date. Following this accrual, Hecker directly holds 2,213 RSUs, including all related dividend equivalent rights. No Rule 10b5-1 trading plan is indicated.

Rhea-AI Summary

UL Solutions Inc. (symbol: ULS) is the issuer of record for a Form 4 filing submitted to the SEC. GOTTSCHALK MARLA C reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. (ULS) reports that director Marla C. Gottschalk received three grants totaling 19 Deferred Restricted Stock Units (DRSUs) on September 10, 2026 as dividend equivalent rights on DRSUs she already holds. Each DRSU represents a contingent right to receive one share of Class A Common Stock and will be settled in shares on a date or events specified under the company’s Non-Employee Director Deferred Compensation Plan.

Rhea-AI Summary

UL Solutions Inc. (symbol: ULS) is the issuer of record for a Form 4 filing submitted to the SEC. Genovesi John A reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. (ULS) reported that Executive Vice President & President, Risk & Compliance Software John A. Genovesi received three small grants of restricted stock units on September 10, 2026, totaling 14 RSUs, each representing a contingent right to receive one share of Class A Common Stock. These RSUs represent accrued dividend equivalent rights on previously granted RSUs and will vest proportionately in three equal installments aligned with the original RSU awards granted on May 1, 2024, April 1, 2025, and April 1, 2026. No Rule 10b5-1 trading plan is reported for these awards.

Rhea-AI Summary

UL Solutions Inc. (symbol: ULS) is the issuer of record for a Form 4 filing submitted to the SEC. DOLLIVE JAMES P reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. (ULS) reported that director James P. Dollive received a grant of 4 Restricted Stock Units (RSUs) on September 10, 2026, representing dividend equivalent rights credited on previously granted RSUs. After this accrual, he holds 2,213 RSUs, including all dividend equivalent rights accrued to date.

Each RSU represents a contingent right to receive one share of UL Solutions Inc. Class A Common Stock. The dividend equivalent rights accrued on these RSUs vest proportionately with the underlying RSUs, which vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026 grant date.

Rhea-AI Summary

UL Solutions Inc. (symbol: ULS) is the issuer of record for a Form 4 filing submitted to the SEC. Dadakis Alex reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. (ULS) reported that Executive Vice President Alex Dadakis received grants of restricted stock units (RSUs) credited as dividend equivalent rights on existing RSUs on September 10, 2026. The awards cover a total of 40 RSUs, each representing one share of Class A Common Stock, vesting in three annual installments tied to prior RSU grant dates in March 2025, April 2025, and April 2026.

Rhea-AI Summary

UL Solutions Inc. reported that executive officer Scott D’Angelo received three separate awards of restricted stock units on September 10, 2026, representing dividend equivalent rights on existing RSUs. The awards cover 11, 4, and 5 RSUs, each convertible into one share of Class A Common Stock at no cost.

The dividend equivalent RSUs tied to earlier grants vest proportionately with their underlying RSUs, in three equal installments on the first, second, and third anniversaries of May 1, 2025 and April 1, 2026, as applicable. No Rule 10b5-1 trading plan is reported for these acquisitions.

Rhea-AI Summary

UL Solutions Inc. (symbol: ULS) is the issuer of record for a Form 4 filing submitted to the SEC. Chapin Linda S reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. (ULS) reported that EVP & CHRO Linda S. Chapin received three small grants totaling 9 Restricted Stock Units on September 10, 2026, all at a stated price of $0.00 per unit. Each RSU represents a contingent right to receive one share of Class A Common Stock and reflects accrual of dividend equivalent rights on previously granted RSUs.

The grants comprise 2 RSUs tied to RSUs vesting in three equal installments on the first, second and third anniversaries of May 1, 2024; 4 RSUs tied to RSUs vesting on the first, second and third anniversaries of April 1, 2025; and 3 RSUs tied to RSUs vesting on the first, second and third anniversaries of April 1, 2026. These dividend equivalents will vest proportionately with the related RSUs, and no Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

UL Solutions Inc. (ULS) reported that President and CEO Jennifer F. Scanlon sold a total of 12,500 shares of Class A common stock on September 1, 2026 under a Rule 10b5-1 trading plan adopted on December 9, 2025. The sales consisted of 10,495 shares at a weighted average price of $73.52 (from trades between $73.21 and $74.20) and 2,005 shares at a weighted average price of $74.43 (from trades between $74.21 and $74.72). The filing also reports 89,285 shares of Class A common stock held indirectly through a family trust, for which Scanlon’s spouse is trustee and her children are beneficiaries.

Rhea-AI Summary

UL Solutions Inc. director Shannon M. James reported a bona fide gift of 600 shares of Class A Common Stock on 2026-08-06. The gift carried a reported per-share value of $0.0000, indicating no consideration was received. Following this gift, James directly holds 6,542 Class A shares.

Rhea-AI Summary

UL Solutions Inc. reports that President and CEO Jennifer F. Scanlon sold a total of 12,500 shares of Class A Common Stock on August 3, 2026, in three open-market transactions under a Rule 10b5-1 trading plan adopted on December 9, 2025. The weighted-average sale prices were $91.0178, $91.8904 and $92.8862 per share, with individual trades executed in ranges from $90.51 to $93.38. She also reports 89,285 shares of Class A Common Stock held indirectly through a family trust, for which her spouse is trustee and her children are beneficiaries.

Rhea-AI Summary

THAMAN MICHAEL H reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. director Michael H. Thaman received a grant of 340 Deferred Stock Units as compensation. Each unit represents one share of Class A Common Stock. After this award, he holds 698 deferred stock units, which are fully vested and will be settled in shares under the company’s non-employee director deferred compensation plan.

Rhea-AI Summary

Kini Vikram reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. director Vikram Kini received a grant of 213 Deferred Stock Units, each representing one share of Class A Common Stock. After this award, he holds 437 Deferred Stock Units in total. The units are fully vested and will be settled in stock under the company’s non-employee director deferred compensation plan.

Rhea-AI Summary

UL Solutions Inc. President and CEO Jennifer F. Scanlon reported open-market sales of 12,500 shares of Class A Common Stock on July 1, 2026. The sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on December 9, 2025, meaning the trades were scheduled in advance.

The reported weighted average sale prices reflect multiple trades within ranges from $97.50 to $101.89 per share. Following these transactions, Scanlon also has indirect ownership of 89,285 shares of Class A Common Stock held by a family trust for which her spouse is trustee and her children are beneficiaries.

Rhea-AI Summary

UL Solutions Inc. director George A. Williams reported acquiring additional deferred restricted stock units (DRSUs) tied to dividend equivalent rights on existing awards. On June 8, 2026, he received 3, 4 and 7 DRSUs, each representing one share of Class A common stock when settled.

The dividend equivalents vest in line with their underlying DRSUs, which vested on May 1, 2025 and May 20, 2026, or will vest by the earlier of May 20, 2027 or the next annual meeting after the 2026 grant. Following these accruals, his DRSU holdings, including accrued dividend equivalents, rose to 4,969 units, to be settled in Class A shares under the company’s Non-Employee Director Deferred Compensation Plan.

Rhea-AI Summary

UL Solutions Inc. executive vice president and chief commercial officer Alberto Uggetti reported routine compensation-related activity involving restricted stock units (RSUs). On June 8, 2026, he acquired small additional RSU amounts through dividend equivalent rights that accrue on RSUs he already holds.

Each RSU represents a contingent right to receive one share of Class A Common Stock. The dividend equivalent rights vest proportionately with the underlying RSUs, which themselves vest in three equal installments on the first, second and third anniversaries of grant dates on May 1, 2024, January 1, 2025, April 1, 2025 and April 1, 2026.

Rhea-AI Summary

UL Solutions Inc. director Elisabeth Torstad reported compensation-related awards of deferred restricted stock units that track the company’s Class A Common Stock. On June 8, 2026, she acquired grants of 3, 4, and 7 deferred restricted stock units (DRSUs), each representing the right to receive one share of Class A Common Stock.

The awards reflect accrued dividend equivalent rights on DRSUs she already held, which vest proportionately with the underlying units. Certain related DRSUs vested on May 1, 2025 and May 20, 2026, while another tranche is scheduled to vest on the earlier of May 20, 2027 or the following annual meeting. After these accruals, Torstad holds 4,969 DRSUs and associated dividend equivalents under the company’s non-employee director deferred compensation plan.

Rhea-AI Summary

THAMAN MICHAEL H reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. director Michael H. Thaman reported a small compensation-related award of 3 Deferred Restricted Stock Units (DRSUs), representing a contingent right to receive 3 shares of Class A Common Stock. These units reflect accrued dividend equivalent rights on existing DRSUs rather than an open-market purchase.

The dividend equivalents vest proportionately with the underlying DRSUs and will fully vest on the earlier of May 20, 2027 or the date of the annual meeting following the May 20, 2026 grant date. After this accrual, Thaman holds a total of 2,209 DRSUs, including all dividend equivalent rights accrued to date.

Rhea-AI Summary

SUSMAN SALLY reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. director Sally Susman reported routine equity compensation in the form of stock units. On June 8, 2026, she received awards of 3 Restricted Stock Units (RSUs), 4 Deferred Restricted Stock Units (DRSUs), and an additional 7 DRSUs, each at a price of $0.00 per unit.

Each RSU or DRSU represents a contingent right to receive one share of Class A common stock. The filing notes that these awards largely reflect accrued dividend equivalent rights on previously granted units, which vest proportionately with the underlying RSUs or DRSUs under the company’s non-employee director deferred compensation plan.

Rhea-AI Summary

Shannon James M reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. director Shannon James M reported three small compensation-related awards of Deferred Restricted Stock Units on June 8, 2026. These awards, totaling 14 units (3, 4, and 7), represent dividend equivalent rights that accrue on existing deferred stock holdings and cost $0.00 per unit.

Each Deferred Restricted Stock Unit represents a contingent right to receive one share of Class A Common Stock. The footnotes explain that these dividend equivalents vest in step with the underlying Deferred Restricted Stock Units and will be settled in Class A shares under the company’s Non-Employee Director Deferred Compensation Plan. After the latest grant, the director holds 4,969 Deferred Restricted Stock Units and related dividend equivalents.

Rhea-AI Summary

Schjotz Gitte reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. executive Gitte Schjotz reported four small grants of restricted stock units (RSUs) tied to dividend equivalent rights on existing RSU awards. Each RSU represents a contingent right to one share of Class A Common Stock, and the related dividend equivalents vest proportionately with the original RSUs in three equal installments on anniversaries of May 1, 2024, January 1, 2025, April 1, 2025 and April 1, 2026.

Rhea-AI Summary

UL Solutions Inc. President and CEO Jennifer F. Scanlon reported three compensation-related equity transactions. On June 8, 2026, she acquired awards of 54, 42, and 32 Restricted Stock Units (RSUs), each at $0.00 per unit and each RSU representing one share of Class A Common Stock.

The footnotes state these RSUs represent accrued dividend equivalent rights on RSUs she already holds. These dividend equivalents vest in three equal installments on the first, second, and third anniversaries of May 1, 2024, April 1, 2025, and April 1, 2026, respectively, matching the vesting schedules of the underlying RSUs.

Rhea-AI Summary

UL Solutions Inc. Executive VP & CFO Ryan D. Robinson reported routine equity compensation activity in the form of Restricted Stock Units (RSUs). On June 8, 2026, he acquired small increments of RSUs representing accrued dividend equivalent rights, each convertible into Class A Common Stock and vesting on the same schedules as the underlying RSU awards.

Rhea-AI Summary

UL Solutions Inc. Senior VP & CAO Karen K. Pepping reported an open-market sale of 725 shares of Class A Common Stock at $97.74 per share. After this sale, she directly holds 8,082 common shares. The filing also records three small awards of Restricted Stock Units (RSUs), each for 1 unit, representing dividend equivalent rights that will convert into one share of Class A Common Stock per unit as they vest. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 6, 2026.

Rhea-AI Summary

UL Solutions Inc. director Vikram Kini reported a small compensation-related equity accrual. On June 8, 2026, he acquired 3 restricted stock units (RSUs) tied to dividend equivalent rights on existing RSU holdings, at a stated price of $0.00 per unit.

Each RSU represents a contingent right to receive one share of Class A Common Stock. After this accrual, Kini directly holds 2,209 RSUs and associated dividend equivalent rights. These RSUs and the related dividend equivalents vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026 grant date.

Rhea-AI Summary

KENNEDY KEVIN reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. director Kevin Kennedy reported routine equity compensation awards tied to his existing stock units. On June 8, 2026, he received 3 Restricted Stock Units (RSUs) and 4 and 7 Deferred Restricted Stock Units (DRSUs), each representing a right to one share of Class A Common Stock.

The RSU and DRSU entries primarily reflect the accrual of dividend equivalent rights on awards he already holds, rather than new open-market purchases. After these grants, his reported direct holdings include 2,209 RSUs and 4,969 DRSUs, which will settle in Class A shares under UL Solutions’ non-employee director deferred compensation framework.

Rhea-AI Summary

Hooper Charles W reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. director Charles W. Hooper reported three small compensation-related grants of Deferred Restricted Stock Units (DRSUs) on June 8, 2026. These awards reflect dividend equivalent rights accruing on DRSUs he already holds, rather than any open-market stock purchases or sales.

Each DRSU represents a contingent right to receive one share of Class A Common Stock, to be delivered under the company’s Non-Employee Director Deferred Compensation Plan. After these accruals, Hooper holds a total of 4,969 DRSUs and related dividend equivalents. The units vest and settle on schedules defined in the plan.

Rhea-AI Summary

Hecker Friedrich reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. director Friedrich Hecker reported an award of 3 Restricted Stock Units (RSUs) as dividend equivalent rights tied to existing RSU holdings. Each RSU represents a contingent right to receive one share of Class A Common Stock.

These dividend-equivalent RSUs vest proportionately with the underlying RSUs and will vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026 grant date. Following this accrual, Hecker holds 2,209 RSUs and related dividend-equivalent rights directly.

Rhea-AI Summary

Hancock Lynn H reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. reported that officer Lynn H. Hancock received several small grants of restricted stock units on June 8, 2026. These RSU entries represent accruals of dividend equivalent rights, with each unit convertable into one share of Class A Common Stock as related RSUs vest over previously disclosed three-year schedules.

Rhea-AI Summary

GOTTSCHALK MARLA C reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. director Marla C. Gottschalk reported routine equity compensation in the form of deferred restricted stock units (DRSUs). On June 8, 2026, she received awards totaling 14 DRSUs, representing a contingent right to receive the same number of shares of Class A Common Stock.

The Form 4 shows three small grant transactions of 3, 4, and 7 DRSUs at a price of $0.00 per unit, all held directly. Footnotes explain these include dividend equivalent rights that accrue on outstanding DRSUs and vest in line with the underlying awards under the company’s Non-Employee Director Deferred Compensation Plan.

Rhea-AI Summary

Genovesi John A reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. officer John A. Genovesi reported three small compensation-related awards of restricted stock units (RSUs) on June 8, 2026. These RSUs represent dividend equivalent rights that accrue on existing RSU holdings and each unit corresponds to one share of Class A Common Stock.

The awards cover 4, 4 and 2 RSUs and relate to prior grants that vest in three equal installments on the first, second and third anniversaries of May 1, 2024, April 1, 2025 and April 1, 2026, respectively. Following these accruals, the filing shows updated RSU-related holdings of 2,960, 2,713 and 1,952 units for the affected grants.

Rhea-AI Summary

DOLLIVE JAMES P reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. director James P. Dollive received a grant of 3 restricted stock units as dividend equivalent rights on existing RSUs. Each RSU represents a contingent right to one share of Class A Common Stock. After this accrual, he holds 2,209 RSUs, including all accumulated dividend equivalents, which vest with the underlying RSUs on the earlier of May 20, 2027 or the annual meeting following the May 20, 2026 grant date.

Rhea-AI Summary

Dadakis Alex reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. officer Alex Dadakis reported routine equity compensation in the form of restricted stock units (RSUs). The filing shows three RSU awards tied to dividend equivalent rights, covering 8, 5 and 15 units of Class A Common Stock.

Each RSU represents a contingent right to receive one share of Class A Common Stock, with dividend equivalent rights accruing on RSUs held. These awards vest proportionately with the underlying RSUs, which themselves vest in three equal installments on the first, second and third anniversaries of March 3, 2025, April 1, 2025 and April 1, 2026, respectively.

Rhea-AI Summary

D'Angelo Scott reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. executive D'Angelo Scott reported routine equity compensation activity involving restricted stock units (RSUs). On June 8, 2026, he received small RSU-related awards of 4, 3, and 8 units tied to Class A Common Stock. These represent dividend equivalent rights that accrue on existing RSUs and vest on the same schedule as the underlying awards. Footnotes explain that each RSU equals one share of Class A Common Stock and that the dividend equivalents vest in three equal installments on the first, second and third anniversaries of either May 1, 2025 or April 1, 2026, depending on the original grant date. The filing also notes the updated RSU balances for Scott after these accruals.

Rhea-AI Summary

UL Solutions Inc. executive Linda S. Chapin, EVP & CHRO, reported several small grants of restricted stock units (RSUs) tied to dividend equivalents on existing RSU awards. On June 8, 2026, she acquired RSUs covering 2, 3, and 2 underlying shares of Class A Common Stock at no cash cost.

Each RSU represents a contingent right to receive one share of Class A Common Stock, and the dividend equivalent rights vest on the same schedule as the related RSUs. Those RSUs vest in three equal installments on the first, second, and third anniversaries of May 1, 2024, April 1, 2025, and April 1, 2026, respectively. The filing shows routine, compensation-related equity accruals rather than any open-market buying or selling.

Rhea-AI Summary

UL Solutions Inc. officer Gitte Schjotz reported open-market sales of a total of 21,880 shares of Class A Common Stock. The transactions included 12,015 shares sold at $99.71 per share on June 2, 2026 and 9,865 shares sold at $96.98 per share on June 3, 2026. After these sales, Schjotz directly holds 59,341 shares. The filing notes these sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on March 3, 2026, indicating they were scheduled in advance rather than timed discretionarily.

Rhea-AI Summary

UL Solutions Inc. President and CEO Jennifer F. Scanlon reported both an equity award and share sales in Class A Common Stock. She received 200,120 performance share units, each representing a contingent right to one share, granted at no cost and tied to future performance and service conditions.

On the same date, she sold a total of 12,500 shares in open-market transactions at weighted average prices around $100 per share, executed under a pre-planned Rule 10b5-1 trading plan. After these sales, she directly held 176,724 shares, with an additional 89,285 shares indirectly held through a family trust, plus the new performance share units that vest between 2029 and 2031 if specified performance metrics are met.

Rhea-AI Summary

UL Solutions Inc. Executive VP & CFO Ryan D. Robinson reported two bona fide gift transfers of Class A Common Stock. On May 29, 2026, he gifted a total of 58,536 shares, with 29,268 shares moved to a trust and 29,268 shares gifted from his direct holdings, all for no consideration.

After these gifts, Robinson holds 165,224 shares indirectly through a trust, where he serves as trustee and his immediate family are beneficiaries, and 1,290 shares directly. The indirect holdings include 290 shares acquired under the Employee Stock Purchase Plan on May 14, 2026. No derivative securities are reported in this filing.